scholarly journals SULFHYDRYL AND DISULFIDE GROUPS OF PROTEINS

1935 ◽  
Vol 18 (3) ◽  
pp. 307-323 ◽  
Author(s):  
A. E. Mirsky ◽  
M. L. Anson
Keyword(s):  
Protein S ◽  
Sh Groups ◽  
Cystine Content ◽  
Cysteine Content

1. Methods have been described for reducing protein S-S groups, for oxidizing protein SH groups, and for estimating protein S-S and SH groups. 2. It has been found necessary in estimating the cystine content of proteins by the Folin-Marenzi method to take into account any cysteine that may be present. 3. A method for estimating the cysteine content of proteins has been described. 4. With these methods, estimations have been made of the S-S and SH groups and of the cystine and cysteine contents of a number of proteins. 5. In a denatured, but unhydrolyzed protein, the number of S-S and SH groups is equivalent to the quantity of cystine and cysteine found in the protein after hydrolysis.

The cysteine content of caseion micelles

1964 ◽  
Vol 31 (3) ◽  
pp. 285-290 ◽  
Author(s):  
R. D. Hill
Keyword(s):  
Enzymic Digestion ◽  
Sh Groups ◽  
Micellar Casein ◽  
Alkaline Conditions ◽  
Cysteine Content

SummaryFollowing enzymic digestion with pronase, masked SH groups in micellar casein became available for titration in disaggregating media with mercurial reagents. The content of cystine and cysteine was also estimated after reduction with (a) sulphite, and (b) borohydride, and also by reaction in alkaline conditions with Cd(OH)2. The results show that the micelles contain mainly cysteine, and that it is likely that cystine is not present.

scholarly journals SULFHYDRYL GROUPS OF EGG ALBUMIN IN DIFFERENT DENATURING AGENTS

1941 ◽  
Vol 24 (6) ◽  
pp. 709-723 ◽  
Author(s):  
A. E. Mirsky
Keyword(s):  
Isoelectric Point ◽  
Guanidine Hydrochloride ◽  
Sulfhydryl Groups ◽  
Color Reaction ◽  
Neutral Medium ◽  
Egg Albumin ◽  
Sh Groups ◽  
Cysteine Content

1. The reaction between ferricyanide and egg albumin in solutions of urea, guanidine hydrochloride, and Duponol has been investigated. 2. In neutral medium ferricyanide oxidizes all the SH groups of egg albumin that give a color reaction with nitroprusside. In neutral medium ferricyanide appears to react only with the SH groups of egg albumin. The quantity of ferrocyanide formed can accordingly be considered the equivalent of the number of SH groups in egg albumin detectable with nitroprusside. 3. In solutions of urea, guanidine hydrochloride, and Duponol sufficiently concentrated so that all the egg albumin present is denatured, the same number of SH groups are found—equivalent to a cysteine content of 0.96 per cent. 4. In denaturation of egg albumin loss of solubility (solubility not in presence of the denaturing agent, but solubility examined in water at the isoelectric point) and appearance of reactive SH groups are integral parts of the same process. As denaturation proceeds in urea, SH groups are liberated only in the egg albumin with altered solubility and in this albumin the maximum number of SH groups is liberated. In a molecule of egg albumin either all of its SH groups that give a test with nitroprusside are liberated or none of them are.

Projected Structure of the Surface Protein of Sulfolobus Spec. B12 Determined to a Resolution of 1.0 NM by Cryo-Electronmicroscopy

1990 ◽  
Vol 48 (1) ◽  
pp. 102-103
Author(s):  
G. Lembcke ◽  
F. Zemlin
Keyword(s):  
Low Dose ◽  
Maximum Dose ◽  
Three Dimensional ◽  
Surface Protein ◽  
Protein S ◽  
Radiation Sensitivity ◽  
Specimen Preparation ◽  
Molecular Architecture ◽  
High Radiation ◽  
Fritz Haber

The thermoacidophilic archaebacterium Sulfolobus spec. B12 , which is closely related to Sulfolobus solfataricus , possesses a regularly arrayed surface protein (S-layer), which is linked to the plasma membrane via spacer elements spanning a distinct interspace of approximately 18 nm. The S-layer has p3-Symmetry and a lattice constant of 21 nm; three-dimensional reconstructions of negatively stained fragments yield a layer thickness of approximately 6-7 nm.For analysing the molecular architecture of Sulfolobus surface protein in greater detail we use aurothioglucose(ATG)-embedding for specimen preparation. Like glucose, ATG, is supposed to mimic the effect of water, but has the advantage of being less volatile. ATG has advantages over glucose when working with specimens composed exclusively of protein because of its higher density of 2.92 g cm-3. Because of its high radiation sensitivity electromicrographs has to be recorded under strict low-dose conditions. We have recorded electromicrographs with a liquid helium-cooled superconducting electron microscope (the socalled SULEIKA at the Fritz-Haber-lnstitut) with a specimen temperature of 4.5 K and with a maximum dose of 2000 e nm-2 avoiding any pre-irradiation of the specimen.

APC Resistance and other Haemostatic Variables during Pregnancy and Puerperium

1999 ◽  
Vol 81 (04) ◽  
pp. 527-531 ◽  
Author(s):  
U. Kjellberg ◽  
N.-E. Andersson ◽  
S. Rosén ◽  
L. Tengborn ◽  
M. Hellgren
Keyword(s):  
Factor Viii ◽  
Plasminogen Activator ◽  
Protein C ◽  
Activated Protein C ◽  
Plasminogen Activator Inhibitor ◽  
Protein S ◽  
Reference Level ◽  
Soluble Fibrin ◽  
Prothrombin Fragment ◽  
D Dimer

SummaryForty-eight healthy pregnant women were studied prospectively and longitudinally. Blood sampling was performed at 10-15, 23-25, 32-34 and 38-40 weeks of gestation, within one week and at eight weeks postpartum. Classic and modified activated protein C ratio decreased as pregnancy progressed. In the third trimester 92% of the ratios measured with the classic test were above the lower reference level whereas all modified test ratios were normal. Slight activation of blood coagulation was shown with increased levels of prothrombin fragment 1+2, soluble fibrin and D-dimer. Fibrinogen, factor VIII and plasminogen activator inhibitor type 1 and type 2 increased. Protein S and tissue plasminogen activator activity decreased. Protein C remained unchanged. No correlation was found between the decrease in classic APC ratio and changes in factor VIII, fibrinogen, protein S, prothrombin fragment 1+2 or soluble fibrin, nor between the increase in soluble fibrin and changes in prothrombin fragment 1+2, fibrinogen and D-dimer.

Beckenvenenthrombose im 16. Lebensjahr bei angeborener Vena-cava-inferior-Atresie und Ecstasy-Abusus

Phlebologie ◽  
2003 ◽  
Vol 32 (02) ◽  
pp. 50-53
Author(s):  
C. Pieck ◽  
P. Sander ◽  
F. G. Bechara ◽  
P. Altmeyer ◽  
M. Stücker
Keyword(s):  
Protein C ◽  
Vena Cava ◽  
Protein S ◽  
Sich Eine ◽  
Farbkodierte Duplexsonographie ◽  
Vena Cava Inferior ◽  
Vena Iliaca ◽  
Vena Femoralis

ZusammenfassungKasuistik: Eine kaukasische Patientin, die sich wegen kosmetisch störender Varizen an der Bauchdecke und den Leisten vorstellte, erlitt mit 16 Jahren während einer exzessiven Tanzveranstaltung unter dem Einfluss von Ecstasy (3,4-Methylendioxymethamphetamin) aus kompletter Gesundheit bei damals asymptomatischer Vena-cava-inferior-Atresie eine akute Beckenvenenthrombose. Diagnostik: Bidirektionale Dopplersonographie, farbkodierte Duplexsonographie, Kernspintomographie mit Magnevist-Kontrastmittel der Venen beider Beine bzw. im Bereich des kleinen Beckens, Bestimmung der Serumkonzentration von Protein C und Protein S, Ausschluss von APC-Resistenz und Faktor-V-Leiden-Mutation. Ergebnisse: In der farbkodierten Duplexsonographie thrombosierte Vena iliaca externa sowie septierte, jedoch suffiziente Vena femoralis communis beidseits, keine Insuffizienzen oder Thromben in den übrigen extraund intrafaszialen Beinvenen nachweisbar. In der Kernspintomographie der Beckenvenen stellte sich eine Hypoplasie der Vena cava inferior oberhalb der Nierenetage und eine Atresie der Vena cava inferior unterhalb der Nierenetage dar sowie ein ausgeprägter venöser Kollateralkreislauf im Bereich des Beckens über die Vv. iliacae internae beidseits und die Vv. lumbales ascendentes beidseits bei varikös entarteten Kollateralvenen im Bereich der Bauchdecke beidseits mit Anschluss an die V. femoralis communis beidseits. Die untersuchten Gerinnungsparameter blieben unauffällig. Schlussfolgerung: Ecstasy-Abusus kann in Kombination mit starker körperlicher Anstrengung zu Exsikkose und Hämokonzetration führen. Dies sehen wir als letzte Ursache der Thrombose bei bestehender Vena-cava-Aplasie.

Molekularbiologische Grundlagen und Diagnostik der hereditären Defekte von Antithrombin III, Protein C und Protein S

2002 ◽  
Vol 22 (02) ◽  
pp. 57-66
Author(s):  
I. Witt
Keyword(s):  
Protein C ◽  
Antithrombin Iii ◽  
Protein S ◽  
Klinische Relevanz ◽  
At Iii

ZusammenfassungDie enormen Fortschritte in der Molekularbiologie in den letzten Jahren ermöglichten sowohl die Aufklärung der Nukleotidsequenzen der Gene für Antithrombin III (AT III), Protein C (PROC) und Protein S (PROS) als auch die Identifizierung zahlreicher Mutationen bei hereditären Defekten dieser wichtigen Inhibitoren des plasmatischen Gerinnungssystems. Da die Gene für AT III (13,8 kb) und PROC (11,2 kb) nicht groß und relativ leicht zu analysieren sind, gibt es bereits umfangreiche »databases« der Mutationen (50, 73). Für AT III sind 79 und für PROC 160 unterschiedliche Mutationen beschrieben.Sowohl beim AT-III-Mangel als auch beim Protein-C-Mangel hat die Mutationsaufklärung neue Erkenntnisse über die Struktur-Funktions-Beziehung der Proteine gebracht. Beim Protein-C-Mangel steht die klinische Relevanz der DNA-Analyse im Vordergrund, da die Diagnostik des Protein-C-Mangels auf der Proteinebene nicht immer zuverlässig möglich ist.Das Protein-S-Gen ist für die Analytik schwer zugänglich, da es groß ist (80 kb) und außerdem ein Pseudogen existiert. Es sind schon zahlreiche Mutationen bei Patienten mit Protein-S-Mangel identifiziert worden. Eine Database ist bisher nicht publiziert. Die klinische Notwendigkeit zur Mutationsaufklärung besteht ebenso wie beim Protein-C-Mangel. Es ist zu erwarten, dass zukünftig die Identifizierung von Mutationen auch beim Protein-S-Mangel beschleunigt vorangeht.

The Frequency of Type I Heterozygous Protein S and Protein C Deficiency in 141 Unrelated Young Patients with Venous Thrombosis

1988 ◽  
Vol 59 (01) ◽  
pp. 018-022 ◽  
Author(s):  
C L Gladson ◽  
I Scharrer ◽  
V Hach ◽  
K H Beck ◽  
J H Griffin
Keyword(s):  
Venous Thrombosis ◽  
Protein C ◽  
Antithrombin Iii ◽  
Young Patients ◽  
Protein S ◽  
Type I ◽  
Protein S Deficiency ◽  
Protein C Deficiency ◽  
Low Protein ◽  
S Deficiency

SummaryThe frequency of heterozygous protein C and protein S deficiency, detected by measuring total plasma antigen, in a group (n = 141) of young unrelated patients (<45 years old) with venous thrombotic disease was studied and compared to that of antithrombin III, fibrinogen, and plasminogen deficiencies. Among 91 patients not receiving oral anticoagulants, six had low protein S antigen levels and one had a low protein C antigen level. Among 50 patients receiving oral anticoagulant therapy, abnormally low ratios of protein S or C to other vitamin K-dependent factors were presented by one patient for protein S and five for protein C. Thus, heterozygous Type I protein S deficiency appeared in seven of 141 patients (5%) and heterozygous Type I protein C deficiency in six of 141 patients (4%). Eleven of thirteen deficient patients had recurrent venous thrombosis. In this group of 141 patients, 1% had an identifiable fibrinogen abnormality, 2% a plasminogen abnormality, and 3% an antithrombin III deficiency. Thus, among the known plasma protein deficiencies associated with venous thrombosis, protein S and protein C. deficiencies (9%) emerge as the leading identifiable associated abnormalities.

Activated Protein C Increases Fibrin Clot Lysis by Neutralization of Plasminogen Activator Inhibitor No Evidence for a Cofactor Role of Protein S

1988 ◽  
Vol 60 (02) ◽  
pp. 328-333 ◽  
Author(s):  
N J de Fouw ◽  
Y F de Jong ◽  
F Haverkate ◽  
R M Bertina
Keyword(s):  
Plasminogen Activator ◽  
Protein C ◽  
Blood Platelets ◽  
Plasminogen Activator Inhibitor ◽  
Protein S ◽  
Tissue Type ◽  
Clot Lysis ◽  
Activator Inhibitor ◽  
Pai 1

summaryThe effect of purified human activated protein G (APC) on fibrinolysis was studied using a clot iysis system consisting of purified glu-plasminogen, tissue-type plasminogen activator, plasminogen activator inhibitor (released from endothelial cells or blood platelets), fibrinogen, 125T-fibrinogen and thrombin. All proteins were of human origin.In this system APC could increase fibrinolysis in a dose dependent way, without affecting fibrin formation or fibrin crosslinking. However, this profibrinolytic effect of APC could only be observed when plasminogen activator inhibitor (PAI-l) was present. The effect of APC was completely quenched by pretreatment of APC with anti-protein C IgG or di-isopropylfluorophosphate. Addition of the cofactors of APC:protein S, Ca2+-ions and phospholipid-alone or in combination did not enhance the profibrinolytic effect of APC. These observations indicate that human APC can accelerate in vitro clot lysis by the inactivation of PAI-1 activity. However, the neutralization of PAI-1 by APC is independent of the presence or absence of protein S, phospholipid and Ca2+-ions.

The Anticoagulant Properties of a Modified Form of Protein S

1988 ◽  
Vol 60 (02) ◽  
pp. 298-304 ◽  
Author(s):  
C A Mitchell ◽  
S M Kelemen ◽  
H H Salem
Keyword(s):  
Monoclonal Antibody ◽  
Anticoagulant Activity ◽  
Activated Protein C ◽  
Factor Xa ◽  
Protein S ◽  
Human Neutrophil Elastase ◽  
Factor X ◽  
Sds Page

SummaryProtein S (PS) is a vitamin K-dependent anticoagulant that acts as a cofactor to activated protein C (APC). To date PS has not been shown to possess anticoagulant activity in the absence of APC.In this study, we have developed monoclonal antibody to protein S and used to purify the protein to homogeneity from plasma. Affinity purified protein S (PSM), although identical to the conventionally purified protein as judged by SDS-PAGE, had significant anticoagulant activity in the absence of APC when measured in a factor Xa recalcification time. Using SDS-PAGE we have demonstrated that prothrombin cleavage by factor X awas inhibited in the presence of PSM. Kinetic analysis of the reaction revealed that PSM competitively inhibited factor X amediated cleavage of prothrombin. PS preincubated with the monoclonal antibody, acquired similar anticoagulant properties. These results suggest that the interaction of the monoclonal antibody with PS results in an alteration in the protein exposing sites that mediate the observed anticoagulant effect. Support that the protein was altered was derived from the observation that PSM was eight fold more sensitive to cleavage by thrombin and human neutrophil elastase than conventionally purified protein S.These observations suggest that PS can be modified in vitro to a protein with APC-independent anticoagulant activity and raise the possibility that a similar alteration could occur in vivo through the binding protein S to a cellular or plasma protein.

Sign in / Sign up

Export Citation Format

Share Document